TrivarX Limited (ASX:TRI)

Market Cap	12.17M
Revenue (ttm)	1.03M
Net Income (ttm)	-943.23K
Shares Out	715.97M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	563,207
Average Volume	1,098,708
Open	0.0170
Previous Close	0.0170
Day's Range	0.0170 - 0.0170
52-Week Range	0.0070 - 0.0350
Beta	0.17
RSI	36.96
Earnings Date	Nov 28, 2025

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 6
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRI

Financial Performance

In 2025, TrivarX's revenue was 1.03 million, an increase of 16.00% compared to the previous year's 888,829. Losses were -943,231, -34.25% less than in 2024.